Horak FB

References (3)

Title : An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical Trial - Shanbhag_2025_JAMA.Neurol__
Author(s) : Shanbhag NM , Padmanabhan JL , Zhang Z , Harel BT , Jia H , Kangarloo T , Yin W , Dowling AV , Laurenza A , Khudyakov P , Galinsky K , Latzman RD , Simuni T , Weintraub D , Horak FB , Lustig C , Maruff P , Simen AA
Ref : JAMA Neurol , : , 2025
Abstract :
PubMedSearch : Shanbhag_2025_JAMA.Neurol__
PubMedID: 39761063

Title : Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease - Mancini_2019_Parkinsonism.Relat.Disord_69_40
Author(s) : Mancini M , Chung K , Zajack A , Martini DN , Ramsey K , Lapidus J , Horak FB , Nutt JG
Ref : Parkinsonism Relat Disord , 69 :40 , 2019
Abstract :
PubMedSearch : Mancini_2019_Parkinsonism.Relat.Disord_69_40
PubMedID: 31675664

Title : Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease - Chung_2010_Neurology_75_1263
Author(s) : Chung KA , Lobb BM , Nutt JG , Horak FB
Ref : Neurology , 75 :1263 , 2010
Abstract :
PubMedSearch : Chung_2010_Neurology_75_1263
PubMedID: 20810998